Abstract
Rationale
An important goal of addiction research is to discover neurobiological markers that could predict the severity of addiction and help to determine appropriate treatment. Brain-derived neurotrophic factor (BDNF) and thiobarbituric acid reactive substances (TBARS) are being related to cerebral plasticity and impairment caused by substance abuse.
Objectives
This study aims to evaluate alteration of TBARS and BDNF levels among crack cocaine users during early drug withdrawal and its relationship to severity of drug use.
Methods
Forty-nine adults crack cocaine users were recruited at a public psychiatric hospital with a specialized addiction treatment unit. Blood sample was collected at intake and discharge for the analysis of TBARS and BDNF measures. Information about drug use was assessed by the Addiction Severity Index 6th Version (ASI-6). Detailed information about crack cocaine use was obtained through the “Profile of the crack cocaine user.” Severity of crack use was estimated using information from age of first crack use, years of crack use, and crack rocks used in the previous 30 days.
Results
There is a positive correlation between TBARS levels and severity of crack cocaine use (R = 0.304, p = 0.04) and a negative correlation between BDNF and severity of crack cocaine use (R = −0.359, p = 0.01) at discharge. Also, we found an inverse correlation between TBARS and BDNF levels (R = −0.294, p = 0.004) at discharge.
Conclusions
Our findings suggest that BDNF and TBARS could be possible markers for the severity of drug use. Further studies may show how those markers could be related to staging, prognosis, and treatment in crack cocaine dependence.
Similar content being viewed by others
References
Andreazza AC, Kauer-Sant’anna M, Frey BN, Bond DJ, Kapczinski F, Young LT et al (2008) Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 111(2–3):135–144
Angelucci F, Ricci V, Pomponi M, Conte G, Mathé AA, Attilio Tonali P et al (2007) Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol 21(8):820–825
Angelucci F, Ricci V, Martinotti G, Palladino I, Spalletta G, Caltagirone C et al (2010) Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. Addict Biol 15(3):365–367
Asevedo E, Gadelha A, Noto C, Mansur RB, Zugman A, Belangero SI et al (2013) Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia. J Psychiatr Res 47(10):1376–1382
Bartkowska K, Turlejski K, Djavadian RL (2010) Neurotrophins and their receptors in early development of the mammalian nervous system. Acta Neurobiol Exp (Wars) 70(4):454–467
Calabrese V, Scapagnini G, Giuffrida Stella AM, Bates TE, Clark JB (2001) Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem Res 26(6):739–764
Castren E (2004) Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol Neurobiol 29(3):289–302
Cerretani D, Fineschi V, Bello S, Riezzo I, Turillazzi E, Neri M (2012) Role of oxidative stress in cocaine-induced cardiotoxicity and cocaine-related death. Curr Med Chem 19(33):5619–5623
Corominas M, Roncero C, Ribases M, Castells X, Casas M (2007) Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction. Neuropsychobiology 55(1):2–13
Corominas-Roso M, Roncero C, Eiroa-Orosa FJ, Gonzalvo B, Grau-Lopez L, Ribases M et al (2013) Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence. Eur Neuropsychopharmacol 23(9):1078–1084
Costa MA, Girard M, Dalmay F, Malauzat D (2011) Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal. Alcohol Clin Exp Res 35(11):1966–1973
Davies KJ (1995) Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 61:1–31
Dias AC, Vieira DL, Gomes LS, Araujo MR, Laranjeira R (2011) Longitudinal outcomes among a cohort of crack users after 12 years from treatment discharge. J Addict Dis 30(3):271–280
D'Sa C, Fox HC, Hong AK, Dileone RJ, Sinha R (2011) Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study. Biol Psychiatry 70(8):706–711
D'Sa C, Dileone RJ, Anderson GM, Sinha R (2012) Serum and plasma brain-derived neurotrophic factor (BDNF) in abstinent alcoholics and social drinkers. Alcohol 46(3):253–259
Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59(12):1116–1127
Dvorakova M, Sivonova M, Trebaticka J, Skodacek I, Waczulikova I, Muchova J et al (2006) The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Rep 11(4):163–172
Filomeni G, Ciriolo MR (2006) Redox control of apoptosis: an update. Antioxid Redox Signal 8(11–12):2187–2192
Fukunaga K, Yoshida M, Nakazono N (1998) A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography. Biomed Chromatogr 12(5):300–303
Fumagalli F, Di Pasquale L, Caffino L, Racagni G, Riva MA (2007) Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur J Neurosci 26(10):2756–2763
Fumagalli F, Moro F, Caffino L, Orrù A, Cassina C, Giannotti G et al (2013) Region-specific effects on BDNF expression after contingent or non-contingent cocaine i.v. self-administration in rats. Int J Neuropsychopharmacol 16(4):913–918
Giannotti G, Caffino L, Calabrese F, Racagni G, Riva MA, Fumagalli F (2014) Prolonged abstinence from developmental cocaine exposure dysregulates BDNF and its signaling network in the medial prefrontal cortex of adult rats. Int J Neuropsychopharmacol 17(4):625–634
Govitrapong P, Boontem P, Kooncumchoo P, Pinweha S, Namyen J, Sanvarinda Y et al (2009) Increased blood oxidative stress in amphetamine users. Addict Biol 15(1):100–102
Grimm JW, Lu L, Hayashi T, Hope BT, Su TP, Shaham Y (2003) Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 23(3):742–747
Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97(6):1634–1658
Hamid A (1992) The developmental cycle of a drug epidemic: the cocaine smoking epidemic of 1981-1991. J Psychoactive Drugs 24(4):337–348
Hauck S, Gomes F, Silveira Júnior EM, Almeida E, Possa M, Ceitlin LH (2009) Serum levels of brain-derived neurotrophic factor in acute and posttraumatic stress disorder: a case report study. Rev Bras Psiquiatr 31(1):48–51
Hauck S, Kapczinski F, Roesler R, de Moura SE, Magalhães PV, Kruel LR et al (2010) Serum brain-derived neurotrophic factor in patients with trauma psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 34(3):459–462
Heberlein A, Muschler M, Wilhelm J, Frieling H, Lenz B, Groschl M et al (2010) BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 34(6):1060–1064
Heberlein A, Muschler M, Frieling H, Lenz B, Wilhelm J, Gröschl M et al (2011) Decreased galanin serum levels are associated with alcohol-craving during withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 35(2):568–572
Henskens R, Garretsen H, Bongers I, Van Dijk A, Sturmans F (2008) Effectiveness of an outreach treatment program for inner city crack abusers: compliance, outcome, and client satisfaction. Subst Use Misuse 43(10):1464–1475
Huang MC, Chen CH, Liu SC, Ho CJ, Shen WW, Leu SJ (2008) Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol 43(3):241–245
Huang MC, Chen CC, Peng FC, Tang SH, Chen CH (2009a) The correlation between early alcohol withdrawal severity and oxidative stress in patients with alcohol dependence. Prog Neuropsychopharmacol Biol Psychiatry 33(1):66–69
Huang MC, Chen CH, Peng FC, Tang SH, Chen CC (2009b) Alterations in oxidative stress status during early alcohol withdrawal in alcoholic patients. J Formos Med Assoc 108(7):560–569
Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J et al (2008) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 32(4):675–692
Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant'Anna M, Klamt F et al (2010) A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry 15(8):784–786
Kessler F, Cacciola J, Alterman A, Faller S, Souza-Formigoni ML, Cruz MS et al (2012) Psychometric properties of the sixth version of the Addiction Severity Index (ASI-6) in Brazil. Rev Bras Psiquiatr 34(1):24–33
Kim DJ, Roh S, Kim Y, Yoon SJ, Lee HK, Han CS et al (2005) High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett 388(2):112–115
Kovacic P (2005) Unifying mechanism for addiction and toxicity of abused drugs with application to dopamine and glutamate mediators: electron transfer and reactive oxygen species. Med Hypotheses 65(1):90–96
Kovacic P, Cooksy AL (2005) Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species. Med Hypotheses 64(2):357–366
Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B (2002) Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology 46(1):27–32
Lee BC, Choi IG, Kim YK, Ham BJ, Yang BH, Roh S et al (2009) Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. Alcohol 43(4):265–269
Li X, DeJoseph MR, Urban JH, Bahi A, Dreyer JL, Meredith GE et al (2013) Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance. J Neurosci 33(3):1130–1142
Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y (2004) A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24(7):1604–1611
Magalhães PV, Jansen K, Pinheiro RT, Colpo GD, da Motta LL, Klamt F et al (2012) Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Int J Neuropsychopharmacol 15(8):1043–1050
McGinty JF, Mendelson JE (2011) Is brain-derived neurotrophic factor a selective biomarker that predicts cocaine relapse outcomes? Biol Psychiatry 70(8):700–701
McGinty JF, Whitfield TW Jr, Berglind WJ (2010) Brain-derived neurotrophic factor and cocaine addiction. Brain Res 1314:183–193
Muriach M, López-Pedrajas R, Barcia JM, Sanchez-Villarejo MV, Almansa I, Romero FJ (2010) Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. J Neurochem 114(3):675–684
Narvaez JC, Magalhães PV, Fries GR, Colpo GD, Czepielewski LS, Vianna P et al (2013) Peripheral toxicity in crack cocaine use disorders. Neurosci Lett 544:80–84
NASCIMENTO ED (ed) (2002) WISC-III e WAIS-III: alterações nas versões originais americanas decorrentes das adaptações para uso no Brasil, FIGUEIREDO VLMd (ed) Vol. 15. Psicol. Reflex. Crit, Porto Alegre
Nestler EJ (2004) Molecular mechanisms of drug addiction. Neuropharmacology 47(Suppl 1):24–32
Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11(6):851–876
Numa R, Kohen R, Poltyrev T, Yaka R (2008) Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization. Neuroscience 155(3):649–658
Paim Kessler FH, Barbosa Terra M, Faller S, Ravy Stolf A, Carolina Peuker A, Benzano D et al (2012) Crack users show high rates of antisocial personality disorder, engagement in illegal activities and other psychosocial problems. Am J Addict 21(4):370–380
Pomierny-Chamiolo L, Moniczewski A, Wydra K, Suder A, Filip M (2012) Oxidative stress biomarkers in some rat brain structures and peripheral organs underwent cocaine. Neurotox Res 23(1):92–102
Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S (2007) Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 22(2):67–73
St Laurent R, Helm SR, Glenn MJ (2013) Reduced cocaine-seeking behavior in heterozygous BDNF knockout rats. Neurosci Lett 544:94–99
Usdan SL, Schumacher JE, Milby JB, Wallace D, McNamara C, Michael M (2001) Crack cocaine, alcohol, and other drug use patterns among homeless persons with other mental disorders. Am J Drug Alcohol Abuse 27(1):107–120
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84
von Diemen L, De Boni R, Kessler F, Benzano D, Pechansky F (2010) Risk behaviors for HCV- and HIV-seroprevalence among female crack users in Porto Alegre, Brazil. Arch Womens Ment Health 13(3):185–191
von Diemen L, Kapczinski F, Sordi AO, de Magalhães Narvaez JC, Guimarães LS, Kessler FH et al (2013) Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal. Int J Neuropsychopharmacol 1–8
Acknowledgments
Thanks go to Dr. Claudia Maciel Szobot, Dr. Ricardo Halpern, and Dr. Anderson Ray Stolf for helping with the collection of data from the control group and to the Molecular Psychiatry Laboratory (HCPA) staff for helping with the laboratorial analysis. This study was funded by Secretaria Nacional de Políticas sobre Drogas (National Secretariat for Alcohol and Drug Policies) of the Brazilian Ministry of Justice.
Conflict of interest
There is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sordi, A.O., Pechansky, F., Kessler, F.H.P. et al. Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal. Psychopharmacology 231, 4031–4039 (2014). https://doi.org/10.1007/s00213-014-3542-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-014-3542-1